Background Long‐term antithrombotic strategies for patients with chronic coronary
syndrome with high‐risk factors represent an important treatment dilemma in clinical …

Current guidelines recommend 6-12 months of dual antiplatelet therapy (DAPT) after
percutaneous coronary intervention (PCI) followed by aspirin monotherapy indefinitely. We …

Coronary artery disease exhibits growing mortality and morbidity worldwide despite the
advances in pharmacotherapy and coronary intervention. Coronary artery disease is …

Aims. Acetylsalicylic acid (ASA) is widely used for the prevention of atherothrombotic events
in patients with chronic coronary artery disease (CAD) and peripheral artery disease (PAD) …

The discovery of the role of platelets in cardiovascular disease led to the introduction of
aspirin as a therapeutic agent for heart disease. Aspirin has proven to be effective in …

Background The benefits and risks of aspirin verse clopidogrel monotherapy in patients with
coronary artery disease (CAD) remain controversial. This meta-analysis evaluated the …

目的分析双重抗血小板治疗(DAPT) 转换在PCI 后发生血小板高反应性(HPR)
的急性冠脉综合征(ACS) 患者中的应用效果及其最佳时间. 方法选取2019 年2 月至2020 年11 …

Purpose of study This study examines the associations between dual antiplatelet therapy
(DAPT) after percutaneous coronary intervention (PCI) and gastrointestinal bleeding (GIB) …

Background The optimal duration of dual antiplatelet therapy is a matter of ongoing
research. Clinical studies are assessing the optimal duration with the most favourable risk to …

Sepelvaltimotaudin vaikeusasteen vaikutus pallolaajennuksen subjektiiviseen
hoitotulokseen Page 1 SEPELVALTIMOTAUDIN VAIKEUSASTEEN VAIKUTUS PALLOLAAJENNUKSEN …